Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the Breast and Prostate Cancer Cohort Consortium (BPC3)

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 2, 2011, Pages

  Beckmann, L ^a   Husing A ^a   Setiawan, V W ^b   Amiano, P ^c,d   Clavel Chapelon, F ^e   Chanock, S J ^f   Cox, D G ^g   Diver, R ^h   Dossus, L ^a   Feigelson, H S ^h   Haiman, C ^b   Hallmans, G ⁱ   Hayes, R B ^j   Henderson, B E ^b   Hoover, R N ^f   Hunter, D J ^k   Khaw, K ^l   Kolonel, L N ^m   Kraft, P ^k   Lund, E ⁿ   Le Marchand, L ^m   Peeters, P H M ^o   Riboli, E ^p   Stram, D ^b   Thomas, G ^f   Thun, M J ^h   Tumino, R ^q   Trichopoulos, D ^r   Vogel, U ^s,t   Willett, W C ^k,u   Yeager, M ^v   Ziegler, R ^f   Hankinson, S E ^u   Kaaks, R ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Public Mental Health Network of Gipuzkoa Osakidetza   (Spain)

^d Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública CIBERESP   (Spain)

^e INSERM   (France)

^f NATIONAL CANCER INSTITUTE   (United States)

^g CENTRE LÉON BÉRARD   (France)

^h AMERICAN CANCER SOCIETY   (United States)

ⁱ UMEÅ UNIVERSITY   (Sweden)

^j NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^l UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^m UNIVERSITY OF HAWAII CANCER CENTER   (United States)

ⁿ UNIVERSITY OF TROMSØ   (Norway)

^o UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^p IMPERIAL COLLEGE LONDON   (United Kingdom)

^q CIVILE M P AREZZO HOSPITAL   (Italy)

^r HELLENIC HEALTH FOUNDATION   (Greece)

^s TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^t NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^u BRIGHAM AND WOMEN S HOSPITAL   (United States)

^v National Cancer Institute   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; ESTRONE; PRASTERONE; STEROID HORMONE; TESTOSTERONE;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ETHNICITY; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE FACTORS; AGED; ALLELES; BODY MASS INDEX; BREAST NEOPLASMS; COHORT STUDIES; ETHNIC GROUPS; EUROPE; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GONADAL STEROID HORMONES; HORMONES; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PREMENOPAUSE; RISK ASSESSMENT; STEROIDS;

EID: 79951703690     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0912     Document Type: Article

References (24)

1. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT, Allen NE, Bueno-de-Mesquita HB, van Gils CH, Grobbee D, Boeing H, Lahmann PH, Nagel G, Chang-Claude J, Clavel-Chapelon F, Fournier A, Thiébaut A, González CA, Quirós JR, Tormo MJ, Ardanaz E, Amiano P, Krogh V, Palli D, Panico S, Tumino R, Vineis P, Trichopoulou A, Kalapothaki V, Trichopoulos D, Ferrari P, Norat T, Saracci R, Riboli E 2005 Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 12:1071-1082 (Pubitemid 41815798)
2. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE 2004 Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96:1856-1865 (Pubitemid 40081323)
3. Thompson DJ, Healey CS, Baynes C, Kalmyrzaev B, Ahmed S, Dowsett M, Folkerd E, Luben RN, Cox D, Ballinger D, Pharoah PD, Ponder BA, Dunning AM, Easton DF 2008 Identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev 17:3490-3498
4. Woolcott CG, Shvetsov YB, Stanczyk FZ, Wilkens LR, White KK, Caberto C, Henderson BE, Le Marchand L, Kolonel LN, Goodman MT2010 Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study. Endocr Relat Cancer 17:125-134
5. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE 2006 Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 98:1406-1415 (Pubitemid 44530717)
6. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E 2005 Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 97:755-765 (Pubitemid 40879595)
7. Dunning AM, Healey CS, Baynes C, Maia AT, Scollen S, Vega A, Rodríguez R, Barbosa-Morais NL, Ponder BA, Low YL, Bingham S, Haiman CA, Le Marchand L, Broeks A, Schmidt MK, Hopper J, Southey M, Beckmann MW, Fasching PA, Peto J, Johnson N, Bojesen SE, Nordestgaard B, Milne RL, Benitez J, Hamann U, Ko Y, Schmutzler RK, Burwinkel B, Schürmann P, Dörk T, Heikkinen T, Nevanlinna H, Lindblom A, Margolin S, Mannermaa A, Kosma VM, Chen X, Spurdle A, Change-Claude J, Flesch-Janys D, Couch FJ, Olson JE, Severi G, Baglietto L, Børresen-Dale AL, Kristensen V, Hunter DJ, Hankinson SE, Devilee P, Vreeswijk M, Lissowska J, Brinton L, Liu J, Hall P, Kang D, Yoo KY, Shen CY, Yu JC, Anton- Culver H, Ziogoas A, Sigurdson A, Struewing J, Easton DF, Garcia- Closas M, Humphreys MK, Morrison J, Pharoah PD, Pooley KA, Chenevix-Trench G 2009 Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 18:1131-1139
8. Haiman CA, Stram DO, Pike MC, Kolonel LN, Burtt NP, Altshuler D, Hirschhorn J, Henderson BE 2003 A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Hum Mol Genet 12:2679-2692 (Pubitemid 37304690)
9. Haiman CA, Dossus L, Setiawan VW, Stram DO, Dunning AM, Thomas G, Thun MJ, Albanes D, Altshuler D, Ardanaz E, Boeing H, Buring J, Burtt N, Calle EE, Chanock S, Clavel-Chapelon F, Colditz GA, Cox DG, Feigelson HS, Hankinson SE, Hayes RB, Henderson BE, Hirschhorn JN, Hoover R, Hunter DJ, Kaaks R, Kolonel LN, Le Marchand L, Lenner P, Lund E, Panico S, Peeters PH, Pike MC, Riboli E, Tjonneland A, Travis R, Trichopoulos D, Wacholder S, Ziegler RG 2007 Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res 67:1893-1897 (Pubitemid 46424203)
10. Haiman CA, Riley SE, Freedman ML, Setiawan VW, Conti DV, Le Marchand L 2005 Common genetic variation in the sex steroid hormone-binding globulin (SHBG) gene and circulating shbg levels among postmenopausal women: the Multiethnic Cohort. J Clin Endocrinol Metab 90:2198-2204
11. Abrahamson PE, Tworoger SS, Aiello EJ, Bernstein L, Ulrich CM, Gilliland FD, Stanczyk FZ, Baumgartner R, Baumgartner K, Sorensen B, Ballard-Barbash R, McTiernan A 2007 Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors. Breast Cancer Res Treat 105:45-54 (Pubitemid 47282743)
12. Cai H, Shu XO, Egan KM, Cai Q, Long JR, Gao YT, Zheng W 2008 Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women. Pharmacogenet Genomics 18:657-664
13. Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, Easton DF, Day NE, Ponder BA 2004 Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 96: 936-945 (Pubitemid 38868140)
14. Hunter DJ, Riboli E, Haiman CA, Albanes D, Altshuler D, Chanock SJ, Haynes RB, Henderson BE, Kaaks R, Stram DO, Thomas G, Thun MJ, Blanché H, Buring JE, Burtt NP, Calle EE, Cann H, Canzian F, Chen YC, Colditz GA, Cox DG, Dunning AM, Feigelson HS, Freedman ML, Gaziano JM, Giovannucci E, Hankinson SE, Hirschhorn JN, Hoover RN, Key T, Kolonel LN, Kraft P, Le Marchand L, Liu S, Ma J, Melnick S, Pharaoh P, Pike MC, Rodriguez C, Setiawan VW, Stampfer MJ, Trapido E, Travis R, Virtamo J, Wacholder S, Willett WC 2005 A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer 5:977-985
15. Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, Pike MC, Stram DO, Monroe KR, Earle ME, Nagamine FS 2000 A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 151:346-357 (Pubitemid 30463612)
16. Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE 2006 Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausalwomenover a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev 15:972-978 (Pubitemid 43823526)
17. Muti P, Trevisan M, Micheli A, Krogh V, Bolelli G, Sciajno R, Berrino F 1996 Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev 5:917-922 (Pubitemid 26382987)
18. Freidlin B, Zheng G, Li Z, Gastwirth JL 2002 Trend tests for case-control studies of genetic markers: power, sample size and robustness. Hum Hered 53:146-152
19. Westfall PH, Young SS 1993 Resampling-based multiple testing: examples and methods for P-value adjustment. New York: Wiley
20. Sowers MR, Wilson AL, Kardia SR, Chu J, Ferrell R 2006 Aromatase gene (CYP 19) polymorphisms and endogenous androgen concentrations in a multiracial/multiethnic, multisite study of women at midlife. Am J Med 119(Suppl 1):S23-S30
21. Lussiana C, Guani B, Mari C, Restagno G, Massobrio M, Revelli A 2008 Mutations and polymorphisms of the FSH receptor (FSHR) gene: clinical implications in female fecundity and molecular biology of FSHR protein and gene. Obstet Gynecol Surv 63:785-795
22. Han B, Li S, Song D, Poisson-Paré D, Liu G, Luu-The V, Ouellet J, Li S, Labrie F, Pelletier G 2008 Expression of 17β-hydroxysteroid dehydrogenase type 2 and type 5 in breast cancer and adjacent nonmalignant tissue: a correlation to clinicopathological parameters. J Steroid Biochem Mol Biol 112:194-200
23. Penning TM, Byrns MC 2009 Steroid hormone transforming aldoketo reductases and cancer. Ann NY Acad Sci 1155:33-42
24. Setiawan VW, Haiman CA, Stanczyk FZ, Le Marchand L, Henderson BE 2006 Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 15:1849-1855 (Pubitemid 44664259)